51 |
The synergism between toll-like receptor 4 agonists and interferon-[gamma] in nitric oxide productionZhao, Rui, January 2005 (has links)
Thesis (M. Phil.)--University of Hong Kong, 2005. / Title proper from title frame. Also available in printed format.
|
52 |
Co-operation between E-cadherin, phosphatidylinositol-3-kinase, Rac and the WASP family protein, WAVE2, is necessary for productive cadherin-dependent contact formation /Ali, Radiya Gulnaz. January 2005 (has links) (PDF)
Thesis (Ph.D.) - University of Queensland, 2005. / Includes bibliography.
|
53 |
Simulations of epidermal growth factor receptor dynamics on corralled membrane surfacesNiehaus, Anne Marie S. January 2007 (has links)
Thesis (M.C.E.)--University of Delaware, 2007. / Principal faculty advisor: Dionisios G. Vlachos, Dept. of Chemical Engineering. Includes bibliographical references.
|
54 |
Characterisation of the C-type lectin receptor Clecsf8Kerscher, Berhard Gerhard Richard January 2016 (has links)
C-type lectin-like receptors (CTLRs) play critical roles in immunity and homeostasis by recognising a variety of microbial or endogenous ligands. Clecsf8 is a member of the Dectin-2 family of CTLRs. Clecsf8 shares important similarities with its relatives Mincle and Dectin-2, such as the lack of an integral signalling motif and a single, calcium dependent ligand binding domain. They were shown to associate with the FcRγ adaptor, which is essential for receptor surface expression and downstream signalling. Recent publications revealed an important role for Clecsf8 in anti-mycobacterial immunity. It was reported to recognise the mycobacterial cord factor (TDM), similar to the related CTLR Mincle, as well as a possible role in candidiasis. In this study, we characterised the underlying mechanism of Clecsf8 expression in a context of mycobacterial disease. The generation of novel anti-Clecsf8 monoclonal antibodies allowed us to characterise the expression of Clecsf8 in detail in homeostasis and inflammation in murine models in vivo and culture systems in vitro. We found Clecsf8 to be predominantly expressed on monocytes/macrophages and neutrophils within e. g. the peritoneal cavity, blood and bone marrow. Notably, Clecsf8 was expressed only weakly in the lung, but strongly upregulated in a pulmonary mycobacterial infection model. In vitro, Clecsf8 expression on elicited macrophages was strongly induced upon treatment with microbial stimuli in a Myd88- and Mincle dependent manner. Interestingly, surface expression of Clecsf8 in a murine fibroblast cell line was greatly enhanced by co-transfection of Mincle, but not another related CTLR, Dectin-2. Notably, we confirmed mycobacteria as a ligand of CLECSF8, but found no role for the receptor in Candida immunity. In conclusion, Clecsf8 is a myeloid expressed, mycobacterial receptor, showing significant interdependence with Mincle and is regulated through the Myd88 pathway.
|
55 |
Regulation of pannexin 1 trafficking by adenosine triphosphateBoyce, Andrew Kenneth Jameson 22 August 2017 (has links)
The ubiquitously expressed pannexin 1 (Panx1) ion- and metabolite-permeable channel is capable of mediating ATP release in a multitude of cells and tissues. This leads to activation of nearby purinergic (P2X/P2Y) receptors in an autocrine/paracrine manner. Stimulation of P2 receptors also triggers Panx1 activation, leading to the formation of a positive feedback loop. Although the focus of Panx1 research has primarily been on its expression at the cell surface, there is robust and stable expression of Panx1 on intracellular membranes. Whether intracellular Panx1 was the consequence of direct diversion from the secretory pathway or internalization from the cell surface was unknown at the onset of my studies. I postulated that Panx1 internalization to these membranes would require a ubiquitous constitutively or episodically released stimulus to allow stable intracellular expression. ATP, a potent signalling molecule released via exocytosis (constitutive or regulated) or large pore channels, fit this criterion. My hypothesis was that ATP triggered Panx1 internalization to intracellular compartments. Upon elevation of extracellular ATP, I observed P2X7R-mediated non-canonical internalization of Panx1 via macropinocytosis. This involved upstream cholesterol-dependent P2X7R-Panx1 clustering via a physical interaction between P2X7R-Panx1 ectodomains and possible contribution of phospholipid (PA, PIP, PIP2) interactions localized to the Panx1 C-terminus. Physical P2X7R-Panx1 interaction may promote Panx1 association with actively endocytosing regions of the membrane. Internalized Panx1 was targeted to slow recycling Rab14/Rab11-positive endosomes in an Arf6-dependent mechanism. The data I presented here provides an additional negative feedback layer to P2X7R-Panx1 crosstalk in the many cell types where they are co-expressed. Further, this is the first evidence demonstrating that Panx1 surface expression is labile to changes in the cellular environment, which contributes to the understanding of the regulation of Panx1 and associated behaviours through trafficking mechanisms. / Graduate / 2018-06-20
|
56 |
Cytokine signalling functions of human soluble IgE receptors in peripheral blood mononuclear cells from normal and hyper-allergic individuals and in B-lymphoblastoid and monocytic cell linesAskew, Sandra Lyn January 2006 (has links)
CD23 is a multifunctional receptor/ligand, found in a variety of cell types, such as human peripheral blood mononuclear cells (PBMCs), B-lymphoblastoid cell lines, mast cells and basophils. It is also found on a variety of haematopoietic cell lines. As the low-affinity receptor for immunoglobulin E (IgE), CD23 plays a role in antigen-presentation and macrophage activation. As a surface molecule cleaved from the cell membrane, soluble CD23 (sCD23) can act as an adhesion molecule and a cytokine. Perturbances of such molecular interactions may lead to various diseases such as allergies and other inflammatory diseases. It has been speculated that elevated levels of sCD23 may be used to bind secreted IgE, thus preventing it from binding to membrane CD23 on haematopoietic cells, preventing B cells from being activated into IgE producing cells. Signal transduction by sCD23 is dependent on cell subsets, ligands and co-factors required for its function. sCD23 plays a direct role in inducing tumour necrosis factor alpha (TNFα), interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) and soluble IL-1 receptor from activated human monocytes and PBMCs in vitro. Recombinant forms of 25 and 37 kDa human sCD23 were produced by polymerase chain reaction (PCR)-cloning into pET23a, a bacterial expression vector. The proteins were expressed and refolded, followed by purification by gel filtration chromatography. The purified proteins were biochemically characterized to ensure purity and biological activity, by observing the binding to human IgE both in enzyme-linked immunosorbant assay (ELISA) and surface plasmon resonance (SPR) spectroscopy. ELISA showed KD values of 7.23 x 10-9M and 8.12 x 10-9M for the 25 and 37 kDa proteins, respectively. These values were significantly lower than that of Hibbert et al., (2005). SPR data obtained for the 25 kDa CD23 was not of reliable quality but SPR for the 33kDa sCD23 showed a KD of 1.18 x 10-7M, close to that of Hibbert et al., (2005), J. Exp. Med, 202: 751-760. To test the therapeutic potential of the recombinant molecule, a B-lymphoblastoid cell line (Raji), a pre-monocytic cell line (U937), and PBMCs from normal and hyper-allergic individuals were used. All cells showed no change in production of cytokines. It is essential to investigate further cytokine functions and production implicated by recombinant forms of sCD23, as well as binding of sCD23 to CD21 and CD11b/c, and in vivo IgE regulation before a conclusion can be drawn as to whether recombinant sCD23 is a potential therapeutic target against allergic disease.
|
57 |
The expression and metabolism of low density lipoprotein receptors in familial hypercholesterolaemiaFourie, Anne Madeleine January 1989 (has links)
The expression of two phenotypically-contrasting LDL receptor mutations was characterized in cultured fibroblasts from the genetically-homozygous Afrikaner subjects, FH1a and lb, and FH3a and 3b, respectively. Surface receptor expression and functional activity were studied by ligand (¹²⁵I-LDL) and monoclonal antibody (¹²⁵I-IgG-C7) binding, and c35s]-methionine pulse-chase experiments were used to analyze biosynthesis, processing and degradation of IgG-C7- immunoprecipitable mutant receptors. Cells from the "receptor-negative" subjects, FH3a and 3b exhibited reduced, but significant (40-60% of normal) LDL receptor synthesis rates. Newly-synthesized precursors were processed slowly (t½ 1.5 hours versus normal t½ of approximately 15 minutes) to mature receptors which reached the cell-surface, but were rapidly degraded thereafter with a half-life of approximately 1.7 hours (normal value 12.6 hours) thus representing a new type of LDL receptor defect. Lysosomotropic weak bases such as ammonium chloride partially inhibited rapid degradation of the mutant receptors, suggesting the involvement of proteolysis in acidic compartments such as lysosomes or endosomes. Fibroblasts from FH1a and lb exhibited normal synthesis rates of LDL receptor precursors that were processed at a severely reduced rate (t½ approximately 5 hours) to functionally heterogeneous mature surface receptors. Onethird of the receptors (20% of normal levels) bound ¹²⁵I-LDL with normal affinity at 4°C and 37°C, whereas the majority were able to recognize only ¹²⁵I-IgG-C7, and apparently showed defective internalisation and subsequent degradation of the bound IgG-C7 at 37°C. The existence of the two receptor populations was further supported by selective intracellular trapping and degradation of only the active, LDL-binding population, in the presence of ammonium chloride and LOL. The abnormal form predominated even in newly-synthesized receptors and reached a maximum of 50-70% of normal levels after 48 hours of upregulation. Upregulation kinetics and degradation rates (t½ = 10-11 hours) of both functionally-active and abnormal receptor populations were similar to normal. A progressive increase in apparent molecular weight of the slowly-processed precursor receptors suggested a possible role for abnormal glycosylation in the formation of both "normal" and abnormal conformations of the same receptor molecule.
|
58 |
Role of chicken toll-like receptor 3 in antiviral responses during H9N2 influenza virus infectionChan, Sze-mei., 陳詩薇. January 2008 (has links)
published_or_final_version / Biological Sciences / Master / Master of Philosophy
|
59 |
Characterization of neutralizing and receptor binding activities in human coronavirus NL63 spike proteinLam, Pui-yi., 林佩儀. January 2009 (has links)
published_or_final_version / Biological Sciences / Doctoral / Doctor of Philosophy
|
60 |
Soluble receptors for advanced glycation end products in type 2 diabetes mellitusTam, Hoi-ling., 譚凱鈴. January 2010 (has links)
published_or_final_version / Medicine / Master / Master of Philosophy
|
Page generated in 0.4415 seconds